Tag Archive for: UiH 2025
https://www.solenomedicalaffairs.com/wp-content/uploads/2025/01/Soleno_MA_Logo.png
0
0
sol3ma
https://www.solenomedicalaffairs.com/wp-content/uploads/2025/01/Soleno_MA_Logo.png
sol3ma2025-06-25 11:00:562025-06-23 20:28:49Diazoxide Choline Extended-Release (DCCR) Tablets Significantly Reduce Hyperphagia in Patients with PWS who are Managed with Strict Food Controls
https://www.solenomedicalaffairs.com/wp-content/uploads/2025/01/Soleno_MA_Logo.png
0
0
sol3ma
https://www.solenomedicalaffairs.com/wp-content/uploads/2025/01/Soleno_MA_Logo.png
sol3ma2025-06-25 11:00:472025-06-23 20:24:40The Emotional Impact of Hyperphagia: Insights from the Prader-Willi Syndrome Community
https://www.solenomedicalaffairs.com/wp-content/uploads/2025/01/Soleno_MA_Logo.png
0
0
sol3ma
https://www.solenomedicalaffairs.com/wp-content/uploads/2025/01/Soleno_MA_Logo.png
sol3ma2025-06-25 11:00:422025-06-23 20:29:20Comparison of Changes in Fat Mass in Participants with PWS Treated with DCCR to Those in the NIH Natural History Study
https://www.solenomedicalaffairs.com/wp-content/uploads/2025/01/Soleno_MA_Logo.png
0
0
sol3ma
https://www.solenomedicalaffairs.com/wp-content/uploads/2025/01/Soleno_MA_Logo.png
sol3ma2025-06-25 11:00:342025-06-23 20:29:51Swallowability and Dosing Compliance of Diazoxide Choline Extended-Release Tablets in Patients with Prader-Willi Syndrome
https://www.solenomedicalaffairs.com/wp-content/uploads/2025/01/Soleno_MA_Logo.png
0
0
sol3ma
https://www.solenomedicalaffairs.com/wp-content/uploads/2025/01/Soleno_MA_Logo.png
sol3ma2025-06-25 11:00:132025-06-23 20:31:10Safety and Efficacy of DCCR in Patients with Prader-Willi Syndrome who have Pre-Diabetes or Diabetes
